Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina Inc (NQ: ILMN )

117.70 +4.53 (+4.00%)
Streaming Delayed Price Updated: 12:53 PM EDT, Jul 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Illumina Inc

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Illumina Stock Dips Late Despite Second-Quarter Beat And Raise
Illumina stock dipped late Thursday after the genetic testing company reported adjusted profit of $1.87 per share on $1.13 billion in sales. 
Via Investor's Business Daily
Illumina Donates $1 Million in Sequencing Capabilities to Mumbai to Support Sequencing-Based COVID-19 Surveillance in India
Illumina Donates $1 Million in Sequencing Capabilities to Mumbai to Support Sequencing-Based COVID-19 Surveillance in India 
Via News Direct
Exposures COVID-19
What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health
What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health 
Via News Direct
Exposures COVID-19
Illumina Celebrates National Intern Day
Illumina Celebrates National Intern Day 
Via News Direct
3 Things About Illumina That Smart Investors Know
The company is cemented as the industry leader, but a crack is showing. 
Via The Motley Fool
After Naming a New CFO, Is This Genetic Diagnostics Company a Buy?
Veracyte appointed Rebecca Chambers, who boasts a wealth of financial executive experience, to the position. 
Via The Motley Fool
Illumina Employees are Encouraged to Invest in Themselves With Annual Health and Lifestyle Allowance
Illumina Employees are Encouraged to Invest in Themselves With Annual Health and Lifestyle Allowance 
Via News Direct
Illumina-Grail $8B Merger Hit By European Commission's In-Depth Investigation
The European Commission has opened an in-depth, three-month investigation into Illumina Inc's (NASDAQ: ILMN) planned takeover of Grail, a deal valued... 
Via Benzinga
The Vaccination of an Entire City in Brazil
How the Butantan Institute helped vaccinate the city of Serrana—and what they learned thereafter 
Via News Direct
Topics Death
Exposures COVID-19 Death
Illumina Wins Reddot 2021 Award: Genomic Sequencing System NextSeq 1000/2000
Illumina Wins Reddot 2021 Award: Genomic Sequencing System NextSeq 1000/2000 
Via News Direct
Delta Defeats Bulls
Stocks tended to crash without rhyme or reason. 
Via Talk Markets
Best And Worst Performances Of The Week
Last week saw US indexes fall along with those of many European countries. However, Japan, Hong Kong, and Chinese markets all rose. 
Via Talk Markets
Illumina Partners With Arab Health in Neonatal and Pediatric Intensive Care Settings
Illumina Partners With Arab Health in Neonatal and Pediatric Intensive Care Settings 
Via News Direct
Apple And Qualcomm Lead The QQQ Higher Wednesday
U.S. indices were trading higher Wednesday as investors weigh comments from Fed Chair Powell. Strength in Apple Inc (NASDAQ: 
Via Benzinga
Topics Economy
Exposures Interest Rates
Illumina, Grail Merger Faces Full-Scale European Probe Amid Antitrust Concerns: Reuters
The proposed $8 billion merger between liquid biopsy firm Grail Inc and cancer blood screening firm Illumina Inc (NASDAQ: ILMN) has met with nothing but flack... 
Via Benzinga
Is Illumina a Buy?
Illumina has gained almost 29% this year and could be headed higher. 
Via The Motley Fool
Revolutionizing Forensics with Illumina’s Next-Generation Sequencing Technology
Othram, Inc. and the NovaSeq help convert more cases from cold to solved 
Via News Direct
Topics Death
Exposures Criminal Death Legal
3 Large-Cap Growth Stocks to Add to Your Portfolio This Summer
Even though investors rotated away from expensive growth stocks earlier this year, select growth stocks have been experiencing strong rebounds and in some instances are making new highs. 
Via Talk Markets
Why Illumina Was Up 17% in June
The company's liquid-biopsy spinoff can reportedly detect early-stage cancer in blood samples. 
Via The Motley Fool
5 Top Stocks for July
These stocks could bring some heat to your portfolio. 
Via The Motley Fool
Has Illumina Lost Its Shine?
Cathie Wood lost her conviction and dumped the stock. Can Illumina get back on track? 
Via The Motley Fool
Topics Regulatory Compliance
Exposures Legal Regulatory
Will Illumina Be a Trillion-Dollar Stock by 2035?
It'll cover a lot of ground in the next 14 years. 
Via The Motley Fool
5 Top ETFs With Exposure To Biogen
For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA. Aducanumab from Biogen Inc (NASDAQ: BIIB) was approved as a drug that... 
Via Benzinga
Exposures Product Safety
This Biotech Just Made History. Will Its Stock Follow?
Twenty years after the human genome was sequenced, a new wave of discovery has begun. 
Via The Motley Fool
Expert Ratings for Illumina
Illumina (NASDAQ:ILMN) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 0 2 1 Somewhat... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2021
Upgrades For Equity Residential (NYSE:EQR), BMO Capital upgraded the previous rating of Market Perform to Outperform. Equity Residential earned $0.68 in the first quarter... 
Via Benzinga
Could Bionano Genomics Be a Millionaire-Maker Stock?
This provider of genome mapping tools is showing signs of exponential growth ahead. 
Via The Motley Fool
These 7 Medical Stocks Are Breaking Down — The Sell Rule You Should Know
Former high-flyers Dexcom and Tandem Diabetes are among seven health care stocks breaking down right now, according to MarketSmith.com. 
Via Investor's Business Daily
Tesla, Nio Significantly Cut From Baillie Gifford Portfolio, Here's What The Firm Bought Instead In Q1
Investment management firm Baillie Gifford shed significant stake in electric carmakers Tesla Inc (NASDAQ: 
Via Benzinga
Is Illumina Sandbagging With Its Full-Year Guidance?
It just might be. 
Via The Motley Fool
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.